0.3637 USD
+0.0137
3.91%
At close Dec 20, 4:00 PM EST
After hours
0.3694
+0.0057
1.57%
1 day
3.91%
5 days
-2.49%
1 month
20.31%
3 months
-52.08%
6 months
-78.09%
Year to date
-89.14%
1 year
-85.85%
5 years
-99.02%
10 years
-96.38%
 

About: Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.

Employees: 430

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

20.99% less ownership

Funds ownership: 54.23% [Q2] → 33.24% (-20.99%) [Q3]

30% less funds holding

Funds holding: 80 [Q2] → 56 (-24) [Q3]

49% less call options, than puts

Call options by funds: $192K | Put options by funds: $379K

68% less capital invested

Capital invested by funds: $16.5M [Q2] → $5.27M (-$11.2M) [Q3]

78% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 27

80% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 30

Research analyst outlook

We haven’t received any recent analyst ratings for CUTR.

Financial journalist opinion

Neutral
Business Wire
1 month ago
Cutera® Announces Partnership with the Adaptive Training Foundation
BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announces their partnership with the Adaptive Training Foundation (ATF), a non-profit organization that provides access and inclusion to individuals living with physical or traumatic impairments empowering them through exercise and community. The Cutera team, with the support of Edward Alvarez, DDS, C.Ac, owner of Madison Avenue Face and Body, has provided ATF participants.
Cutera® Announces Partnership with the Adaptive Training Foundation
Neutral
Seeking Alpha
1 month ago
Cutera, Inc. (CUTR) Q3 2024 Earnings Call Transcript
Cutera, Inc. (NASDAQ:CUTR ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Shelby Eckerman - Vice President of Finance Taylor Harris - Chief Executive Officer Stuart Drummond - Interim-Chief Financial Officer Conference Call Participants Jonathan Block - Stifel Anthony Vendetti - Maxim Group Macauley Kilbane - William Blair Operator Thank you for standing by. This is the conference operator.
Cutera, Inc. (CUTR) Q3 2024 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
Cutera (CUTR) Reports Q3 Loss, Misses Revenue Estimates
Cutera (CUTR) came out with a quarterly loss of $1.85 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to loss of $1.61 per share a year ago.
Cutera (CUTR) Reports Q3 Loss, Misses Revenue Estimates
Neutral
Business Wire
1 month ago
Cutera® Announces Third Quarter 2024 Financial Results
BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today reported financial results for the third quarter ended September 30, 2024. Consolidated revenue for the third quarter of 2024 of $32.5 million Cash, cash equivalents, and restricted cash of $59.0 million AviClear growth of 16% vs prior year period driven by international capital system sales Global core capital growth of 7% on a sequential quarterly basis Full-year gu.
Cutera® Announces Third Quarter 2024 Financial Results
Neutral
Business Wire
2 months ago
Cutera® to Announce Third Quarter Results on November 7, 2024
BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will report financial results for the third quarter ended September 30, 2024, after the market closes on Thursday, November 7, 2024. The Company's management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m ET) that same day. Participants can register for the conference call at the following registrat.
Cutera® to Announce Third Quarter Results on November 7, 2024
Negative
GuruFocus
2 months ago
Cutera (CUTR) Stock Drops 5.14% Amid Financial Challenges
Cutera Inc. (CUTR, Financial) experienced a significant stock price decline of 5.14%, bringing its price to $0.751 per share. The trading volume reached 26,733 shares, with a turnover rate of 0.13% and a price fluctuation of 5.03%.
Cutera (CUTR) Stock Drops 5.14% Amid Financial Challenges
Neutral
Seeking Alpha
4 months ago
Cutera, Inc (CUTR) Q2 2024 Earnings Call Transcript
Cutera, Inc (NASDAQ:CUTR ) Q2 2024 Results Conference Call August 8, 2024 4:30 PM ET Company Participants Shelby Eckerman - Vice President of Finance Taylor Harris - Chief Executive Officer Stuart Drummond - Chief Financial Officer Conference Call Participants Jordan Bernstein - Stifel Harrison Parson - Stephens James Beer - William Blair Operator Thank you for standing by. This is the conference operator.
Cutera, Inc (CUTR) Q2 2024 Earnings Call Transcript
Negative
Zacks Investment Research
4 months ago
Cutera (CUTR) Reports Q2 Loss, Misses Revenue Estimates
Cutera (CUTR) came out with a quarterly loss of $1.20 per share versus the Zacks Consensus Estimate of a loss of $0.90. This compares to loss of $0.69 per share a year ago.
Cutera (CUTR) Reports Q2 Loss, Misses Revenue Estimates
Neutral
Business Wire
4 months ago
Cutera® Announces Second Quarter 2024 Financial Results
BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today reported financial results for the second quarter ended June 30, 2024. Consolidated revenue for the second quarter of 2024 of $34.4 million Cash, cash equivalents, and restricted cash of $84.3 million AviClear growth of 41% vs prior year period driven by international capital system sales Service growth of 7% vs prior year period, highlighting improvements in field se.
Cutera® Announces Second Quarter 2024 Financial Results
Neutral
Business Wire
4 months ago
Cutera® Announces Exclusive Distribution Agreement With L'Oréal® for SkinCeuticals® Products in Japan
BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, and its Japanese subsidiary, Cutera KK, are pleased to announce a strategic partnership with L'Oréal Japan Co. to exclusively promote, market, sell and distribute select SkinCeuticals products to medical and physician-led clinics in Japan. "We are excited about this collaboration with L'Oréal Japan Co. to bring SkinCeuticals' renowned skincare innovations to aesthetic provi.
Cutera® Announces Exclusive Distribution Agreement With L'Oréal® for SkinCeuticals® Products in Japan
Charts implemented using Lightweight Charts™